Photobiomodulation Explained: What Light Can Change in Cells
LIGHT THERAPY · FOUNDATIONS
What light can change in cells—and what that cannot tell you about your skin.
Photobiomodulation research connects light absorption with changes in cellular activity. Understanding those connections helps you read a skin claim without mistaking a proposed mechanism for a demonstrated result.
Short answer: Photobiomodulation (PBM) uses light to influence biological activity through molecules that absorb it. Experiments report changes in mitochondrial function, chemical signaling and gene expression, but the response depends on the light exposure and the cells studied. A rise in a cellular marker does not establish wrinkle reduction or another visible benefit in people. For a skin outcome, look for matching human evidence; for safe use, follow the specific device’s instructions. [1] [2]
Why a mechanism does not prove a skin benefit
“Light activates cells” leaves out the most useful questions: which cells, under which conditions, and what changed? An experiment measuring adenosine triphosphate (ATP), a molecule used in cellular energy transfer, answers a different question from a trial measuring facial wrinkles. Neither the word “human” in “human fibroblasts” nor a plausible explanation closes that gap. Cells grown in a dish are still laboratory evidence. [1] [3]
A useful evidence chain has three separate steps:
- Light interacts with a biological target. Identify a candidate absorber and investigate how exposure affects it.
- A response occurs in cells or tissue. Measure a biochemical or structural change under defined experimental conditions.
- People experience the intended outcome. Test the relevant appearance measure against an appropriate comparison, with the actual exposure described.
The first two steps can explain why a human trial is worth doing. They cannot supply the third step’s result. This is an evidence distinction, not a dismissal of PBM: a treatment can have useful clinical evidence even while parts of its mechanism remain unsettled.
The American Academy of Dermatology (AAD) describes encouraging skin research but also notes that differences in devices, exposure times and study questions make at-home effectiveness difficult to judge. That uncertainty belongs alongside the mechanism, rather than being replaced by an ATP-based promise. [2]
How light absorption can become a cellular signal
A chromophore is a molecule that absorbs light
For a photochemical response, light must first be absorbed. A chromophore is the absorbing molecule or molecular group. Its absorption properties help determine which wavelengths can interact with it. Seeing a red glow tells you the light is visible; it does not establish which cellular target absorbed enough light to produce a particular response. [3]
In red and near-infrared PBM research, a frequently discussed candidate is cytochrome c oxidase (CCO), an enzyme in the mitochondrial electron transport chain. That chain helps establish the conditions for ATP production. One proposed explanation is that light alters interactions between CCO and nitric oxide, affecting respiration and downstream signaling. [3]
The CCO explanation is a hypothesis with disputed details
It is too strong to present “light releases nitric oxide, so every skin cell makes more ATP” as a settled sequence. Quirk and Whelan’s evidence review questions the reproducibility and physiological relevance of several CCO findings and discusses alternative roles for nitric oxide. It does not settle every PBM mechanism, but it shows why the familiar mitochondrial diagram should be read as a proposed explanation. [4]
Other proposed pathways involve light-sensitive receptors and ion channels that influence calcium signaling. Their relevance depends on the wavelength and biological system; listing more candidate pathways does not strengthen a device’s cosmetic evidence. [3]
Signaling is more complex than “extra energy”
PBM experiments also investigate reactive oxygen species (ROS), calcium and transcription factors—proteins that help regulate gene expression. ROS can participate in signaling as well as oxidative damage. “More ROS” is therefore not automatically beneficial, and “less ROS” does not explain every response. Hamblin’s redox review describes different responses in healthy and experimentally stressed cells, including findings in cultured mouse neurons. Those observations cannot be relabeled as facial rejuvenation in people. [5]
Changes in fibroblasts, which help produce the skin’s extracellular matrix, are relevant research leads. However, a change in collagen-related gene expression or a precursor protein does not itself show the amount, organization or persistence of collagen in a living face. Those questions require additional tissue and human outcome evidence. [1]
Why the light parameters change the interpretation
“Red light” is a category, not a complete experimental description. PBM reviews describe effects that vary with exposure conditions, including non-linear responses in laboratory models. This does not establish a universal ideal dose or a rule for adjusting a home device. [3] [5]
| Parameter | What it describes | Why it matters |
|---|---|---|
| Wavelength and spectrum | Which wavelengths are emitted, usually described in nanometers (nm). | Absorption and tissue transmission depend on wavelength; a color name is incomplete. |
| Irradiance | Optical power reaching a unit area, such as mW/cm². | Electrical wattage or LED count does not provide this measurement at the skin. |
| Radiant exposure and time | Energy per area, commonly J/cm², and how long it is delivered. | The same energy per area delivered at different irradiances is not necessarily biologically equivalent. |
| Pulse structure | Continuous or pulsed delivery; pulse width, frequency and duty cycle where relevant. | Average output alone can hide differences in the exposure. |
| Geometry and site | Illuminated area, placement, distance and anatomical target. | Surface exposure does not specify the amount reaching each tissue layer. |
| Biological context | Cell type, tissue condition and study population. | A stressed cell culture and intact human skin are different test systems. |
These are study-reading checks, not settings to copy. The parameter review explains why energy density alone is an incomplete description and reports laboratory examples where changing irradiance while holding energy density constant changed the response. [3]
PBM refers here to light-induced modulation that does not rely on deliberately heating or destroying tissue. Low-level lasers and LEDs can be studied for PBM, but a laser study is not automatically evidence for an LED mask. UV phototherapy, intense pulsed light (IPL), heat-based infrared treatment and photosensitizer-based photodynamic therapy (PDT) require separate evidence. PDT can use an LED light source while still being a different intervention. [3]
How to check what a PBM claim actually proves
| Claim you encounter | Check in the source | Conclusion it cannot supply on its own |
|---|---|---|
| “Increases ATP” | Was ATP measured directly? In which cells, at what exposure, and compared with what? | A visible anti-aging result or a reason to increase exposure. |
| “Stimulates collagen” | Was the endpoint gene expression, a precursor protein, tissue collagen or an appearance measure? | Equivalent wrinkle improvement across devices. |
| “Supported by human research” | Were living participants treated, or were isolated human cells studied? | A clinical result when the experiment was performed in a dish. |
| “Study showed improvement” | What was the comparator? Were assessment, magnitude, follow-up and adverse events reported? | A meaningful, durable benefit for every user. |
This checklist translates the distinction between mechanistic and clinical evidence into practical questions. For a salon team, it also helps keep an explanation accurate: describe a cellular result as a cellular result. Do not turn it into a client outcome or attach it to a different device merely because both emit red light. [1] [2]
Three common misunderstandings
- “Biologically active means visibly effective.” A measurable change may be too small, too brief or unrelated to the appearance outcome being advertised.
- “More light means more benefit.” Laboratory dose-response findings do not justify longer sessions or combining devices. [3]
- “A mechanism paper validates the product.” It supports only its actual experimental scope; the product and intended outcome still need matching evidence.
A plausible mechanism is not a safety assessment
The AAD advises discussing suitability with a dermatologist, particularly when a light-sensitive condition or medication is involved. It also flags pigment-related concerns in darker skin tones and uncertainty about long-term effects. Do not stop or alter a medication to make light exposure possible without medical guidance. [2]
Use the specific device’s directions for exposure, placement and required eye protection. The AAD advises using the recommended protection rather than substituting sunglasses. If exposure causes pain or irritation, stop and seek advice before continuing; these are adverse symptoms, not evidence that the cells are “working harder.” [2]
This mechanism discussion does not establish suitability during pregnancy or breastfeeding, over an implant, on a diseased area, or alongside another procedure. Those questions need the relevant instructions and clinical assessment. No universal schedule follows from the mechanisms described here.
Common questions
Can a PBM treatment work before its mechanism is fully understood?
Yes. Controlled human outcome evidence can support a specific intervention without resolving every molecular step. Conversely, an elegant mechanism cannot replace a missing human outcome study. Ask these two questions separately.
Does a statistically significant biomarker change mean I will notice a difference?
No. Statistical evidence concerns a measured result under a study’s conditions. Whether a change is visible, worthwhile or persistent depends on the endpoint, magnitude and follow-up. ATP measurements cannot answer a wrinkle question by themselves.
Does “nonthermal” mean the device can never feel warm?
No. The term describes the intended biological mechanism, not a guarantee about every device or exposure. Warmth is not a dose meter or proof of benefit. Follow the device’s limits rather than using heat as a reason to extend a session. [3]
Read the mechanism, then check the outcome
PBM provides a framework for investigating how absorbed light influences cells. The strongest reading of a skin claim keeps the absorber, experimental response and human appearance outcome distinct. A mechanism explains a possibility; matching clinical evidence determines what can be said about a result.
Sources
- Hernández-Bule et al. (2024). Unlocking the Power of Light on the Skin: A Comprehensive Review on Photobiomodulation. Narrative review; includes multiple technologies and evidence types.
- American Academy of Dermatology. Is red light therapy right for your skin? Professional patient education; not an exact-device protocol.
- de Freitas and Hamblin (2016). Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. Mechanistic review; laboratory findings are not universal skin-use settings.
- Quirk and Whelan (2020). What Lies at the Heart of Photobiomodulation: Light, Cytochrome C Oxidase, and Nitric Oxide—Review of the Evidence. Critical mechanistic review.
- Hamblin (2018). Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Mechanistic review across experimental systems.
Sources checked October 10, 2026. No specific commercial device or treatment protocol is evaluated here.
This article is for general educational purposes and does not provide medical advice. Follow the instructions for the specific device and consult a qualified healthcare professional about suitability and safety.